Fingerprint
Dive into the research topics of 'Treatment value of second-generation BCR-ABL1 tyrosine kinase inhibitors compared with imatinib to achieve treatment-free remission in patients with chronic myeloid leukaemia: a modelling study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically